Bill Texts: US HB679 | 2025-2026 | 119th Congress

Bill Title: To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

Spectrum: Partisan Bill (Republican 17-0)

Status: (Introduced) 2025-01-23 - Referred to the House Committee on Energy and Commerce. [HB679 Detail]

Bill Drafts

RevisionDateFormatSourceView
Introduced2025-02-21PDFLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for US Congress HB679

Supplemental Documents

TitleDescriptionDateFormatSourceView
No supplemental documents for US Congress HB679 currently on file.

Social Comments on US HB679

feedback